Jean-Charles Wirth and Danny Bar-Zohar are set to assume the life science and healthcare CEO roles respectively.

Outsourcing services are on of the pillars of Merck's business, delivered via its process solutions unit, part of the group's life sciences division. The unit contributed almost €3.4 billion out ...

FRANKFURT, Feb 18 (Reuters) - Germany's Merck KGaA (MRCG.DE), opens new tab ... Jean-Charles Wirth is to become the CEO of the Life Science unit, a maker of gear and supplies for biotech labs ...

The CEO of Germany's Merck KGaA on Thursday said a recovery in sales growth at its existing business means it can take a cautious approach to buying other companies, which are expensively priced.

with trillions spent on life sciences R&D every year to advance new drug discoveries. That R&D takes place not only at big pharma companies—household names such as Pfizer and Merck—but also at smaller ...

Merck on Tuesday missed earnings estimates, lowered its guidance for this year’s earnings, and withdrew a target for sales of its HPV vaccine, Gardasil, to reach $11 billion by 2030. The result ...

U.S. investors and large pharmaceutical companies are increasingly doing deals in China as the country’s biopharma sector ...

Gilead Sciences has defied analysts’ expectations by passing on its chance to license Arcus Biosciences’ potential rival to Merck & Co.’s kidney cancer drug Welireg.

About the Life Science business of Merck KGaA, Darmstadt ... by email at the same time they become available on the EMD Group website. In case you are a resident of the U.S. or Canada please ...